ARDX · Ardelyx Inc
United States · RS rating 13 · As of 2026-11-03
| Price | 3.03 USD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 13 / 34 / 15 / 21 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 26 / 4 / 42 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +53.3% |
| Sales growth Q/Q | +13.5% |
| Distance from 52-week high | +62.1% |
| Market cap (USD) | $1.5B |